Active not recruiting

A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis (Eczema) (BREEZE-AD3)

I4V-MC-JAHN - ClinicalTrials.gov - NCT03334435

The purpose of this study is to evaluate the long-term safety and efficacy of baricitinib in participants with atopic dermatitis (eczema).
How long will I be in the trial?
Your participation could last up to 108 weeks and include up to 17 visits to the study center.
Email
Active not recruiting

A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis (Eczema) (BREEZE-AD3)

I4V-MC-JAHN - ClinicalTrials.gov - NCT03334435

The purpose of this study is to evaluate the long-term safety and efficacy of baricitinib in participants with atopic dermatitis (eczema).
How long will I be in the trial?
Your participation could last up to 108 weeks and include up to 17 visits to the study center.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have met participation requirements for a previous atopic dermatitis (eczema) study

Participants must have completed the final treatment visit in a previous baricitinib atopic dermatitis (eczema) study

Participants must NOT

Participants must not have permanently stopped taking baricitinib during a previous baricitinib study

Trial Summary

Conditions the trial is for

Atopic Dermatitis (Eczema)

What the trial is testing?

Baricitinib

Could I receive a Placebo?

yes

Enrollment Goal

1660

Trial Dates

March 2018 - September 2023

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have met participation requirements for a previous atopic dermatitis (eczema) study

Participants must have completed the final treatment visit in a previous baricitinib atopic dermatitis (eczema) study

Participants must NOT

Participants must not have permanently stopped taking baricitinib during a previous baricitinib study

Trial Summary

Conditions the trial is for

Atopic Dermatitis (Eczema)

What the trial is testing?

Baricitinib

Could I receive a Placebo?

yes

Enrollment Goal

1660

Trial Dates

March 2018 - September 2023

Trial Phase

3

Not the right fit? Sign up to receive updates on new Atopic Dermatitis (Eczema) trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Atopic Dermatitis (Eczema) Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?